BOTOX COSMETIC (onabotulinumtoxina) by AbbVie is acetylcholine release inhibitors [moa]. Approved for acetylcholine release inhibitor [epc]. First approved in 1991.
Drug data last refreshed 19h ago · AI intelligence enriched 1w ago
BOTOX COSMETIC is an injectable formulation of onabotulinumtoxinA, a neurotoxin that inhibits acetylcholine release at the neuromuscular junction. It is indicated for cosmetic treatment of glabellar lines, crow's feet, and facial rhytides, as well as therapeutic uses including chronic migraine, cervical dystonia, and overactive bladder. The drug works by blocking acetylcholine signaling to produce temporary muscle paralysis and wrinkle reduction.
The product is approaching loss of exclusivity with moderate competitive pressure (30%), signaling potential team restructuring and a shift toward cost management and retention strategies.
Acetylcholine Release Inhibitors
Acetylcholine Release Inhibitor
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study to Assess the Adverse Events of Intramuscular Injections of AGN-151586 and OnabotulinumtoxinA in Adult Participants for the Change of Glabellar Lines (GL)
A Study to Assess Adverse Events and Effectiveness of OnabotulinumtoxinA Intramuscular Injections for the Change of Moderate to Severe Forehead Lines in Adult Participants
A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products
A Study to Evaluate Adverse Events and Effectiveness of OnabotulinumtoxinA in Participants Undergoing Open Abdominal Ventral Hernia Repair for the Achievement of Primary Fascial Closure Without the Use of Component Separation Technique
A Study to Evaluate Participant Satisfaction and Natural Outcomes Following Administration of BOTOX Cosmetic Injections in Adult Participants for Treatment of Upper Facial Lines
Worked on BOTOX COSMETIC at AbbVie? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Upgrade to Pro to access CMS Part B ASP pricing data and other premium pharma intelligence.
Upgrade to Pro — $25/moOnly 1 linked job opportunity exists for BOTOX COSMETIC, concentrated in Finance—a strong indicator that the product is in cost-rationalization and profitability optimization mode rather than growth expansion. Working on this product likely involves financial planning around LOE transition, cost structure reduction, and revenue forecasting in a contracting market.
1 open roles linked to this drug